Announced Wed, 27 May · 20:01 IST

Emcure Pharmaceuticals Limited has informed the Exchange regarding allotment of 70000 securities pursuant to ESOP/ESPS at its meeting held on May 27, 2026

Capital Market Events View source PDF

EMCURE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-1.0%1-day move
₹1724.00
prior close
₹1739.90
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.4-0.6-0.6+0.4-1.0-1.4-1.6+0.9+2.1+1.1+3.2+6.9
Up moveDown movePending
AI summary

Emcure Pharmaceuticals has allotted 70,000 equity shares of Rs. 10 each to eligible employees upon exercise of vested options under the company's Employee Stock Option Scheme 2013. The allotment was approved by the Nomination and Remuneration Committee via resolution passed on May 27, 2026. Following this, the company's paid-up share capital increased from 18,95,89,547 shares to 18,96,59,547 shares. The newly allotted shares will rank equally with existing equity shares in all respects. This is a routine ESOP exercise with minimal dilution impact of approximately 0.004%.

Likely market impact

The allotment has negligible impact on shareholders as the dilution is minimal. This is a standard corporate action reflecting employee compensation through equity, which is routine for listed companies.